Filtered Search Results
R&D Systems™ Recombinant Human His6-alpha-Synuclein Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
R&D Systems™ Recombinant Human Erythropoietin/EPO (Tissue Culture Grade)
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Mouse VSIG4 Fc Chimera Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
R&D Systems™ Recombinant Mouse Lymphotoxin alpha2/beta1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 18.5 kDa (LT alpha), 18.4 kDa (LTbeta) |
| Gene ID (Entrez) | 16992 |
| Quantity | 10 μg |
| Structural Form | Noncovalently-linked heterotrimer |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | Spodoptera frugiperda,Sf 21 (baculovirus)-derived mouse Lymphotoxin protein Leu34-Leu202 (LT alpha ) & Gly136-Gly306 (LT beta ) |
| Recombinant | Recombinant |
| Name | Lymphotoxin α2/β1 |
R&D Systems™ Recombinant Cynomolgus Lymphotoxin beta R/TNFRSF3 Fc, CF
Carrier-Free Recombinant Protein
R&D Systems™ Recombinant Mouse Erythropoietin/EPO Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human VSIG4 (aa 20-283) Fc Chimera Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
| Accession Number | Q9GZX6.1 |
|---|---|
| Conjugate | Unconjugated |
| Gene Alias | Cytokine Zcyto18, IL-10-related T-cell-derived inducible factor, IL22, IL-D110, IL-TIF, ILTIFIL-10-related T-cell-derived-inducible factor, IL-TIFMGC79382, interleukin 22, interleukin-22, MGC79384, TIFa, TIFIL-23, zcyto18 |
| Molecular Weight (g/mol) | M.W. Observed: 28-32 kDa, under reducing conditions., M.W. Theoretical: 17 kDa |
| Gene ID (Entrez) | 50616 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
| Reconstitution | Reconstitute the 10 μg size at 100 μg/mL in PBS. Reconstitute all other sizes at 500 μg/mL in PBS. |
| For Use With (Application) | Bioactivity |
| Protein | IL-22 |
| Source | Human embryonic kidney cell, HEK293-derived human IL-22 protein Ala34-Ile179 |
| Accession Number | Q969D9.1 |
|---|---|
| Purity or Quality Grade | >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Conjugate | Unconjugated |
| Gene Alias | thymic stromal lymphopoietin |
| Molecular Weight (g/mol) | M.W. Observed: 19-26 kDa, under reducing conditions., M.W. Theoretical: 16 kDa |
| Gene ID (Entrez) | 85480 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
| Reconstitution | Reconstitute the 10 μg size at 100 μg/mL in PBS. Reconstitute all other sizes at 500 μg/mL in PBS. |
| Endotoxin Concentration | <0.10 EU per 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | TSLP |
| Source | Human embryonic kidney cell, HEK293-derived human TSLP protein Tyr29-Gln159 (Arg127Ala, Arg130Ala), with a C-terminal 10-His tag |
Tocris Bioscience™ Biotin-11-dUTP
Greener Choice Product
This product offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More About the Greener Choice Program
This product offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More About the Greener Choice Program
Biotin-labeled dUTP
R&D Systems™ Recombinant Human Lymphotoxin alpha2/beta1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 18 kDa (LT alpha), 18.5 kDa ( LTbeta) |
| Gene ID (Entrez) | 4049 |
| Quantity | 10 μg |
| Structural Form | Noncovalently-linked heterotrimer |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | Spodoptera frugiperda,Sf 21 (baculovirus)-derived human Lymphotoxin protein Leu35-Leu205 (LT alpha ) & Leu54-Gly244 (LT beta ),both with an N-terminal Met & Thr41-Leu205 (LT alpha ) |
| Recombinant | Recombinant |
| Name | Lymphotoxin α2/β1 |